Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI

February 17, 2020 updated by: Milap Sandhu, Shirley Ryan AbilityLab

Timing and Dosage Parameters of Acute Intermittent Hypoxia in Individuals With Spinal Cord Injury.

This study will utilize short duration and mild levels of reduced oxygen (hypoxia) to induce spinal plasticity while evaluating the appropriate timing schedule for this intervention, as well as, the effects of superimposing sessions of a therapy, in individuals with chronic incomplete SCI. Our aim is to establish the time-course of outcome improvement and decay following a single session or multiple sessions of AIH therapy.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Rehabilitation Institute of Chicago
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Spinal cord lesion at level of C3 to T1
  2. Individuals with a history of incomplete spinal cord injury, classified as ASIA C or D
  3. Individuals must be at least 6 months status post injury
  4. Individuals must be between the ages of 18-70 years inclusive, male or female
  5. Spinal cord injury must be secondary to a non-progressive etiology
  6. Individuals must be medically stable.
  7. Able to comply with protocol/study requirements
  8. Not currently (>2 weeks) taking any medications for spasticity management.

Exclusion Criteria:

  1. Recent change in the use of narcotic, anti-inflammatory or pain medication
  2. Unstable medical conditions or any other clinical observation that may affect the candidate's performance, health, safety or the ability to participate in the study, as determined by the treating therapist
  3. History of sleep apnea
  4. Active participation in another movement research study or therapy program
  5. Anti-spasticity drug injection less than 3 months, prior to beginning treatment
  6. Musculoskeletal pain that interferes with participation in study
  7. Women who are currently, may be or planning on becoming pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single session of Acute Intermittent Hypoxia (AIH)
Patients will breath 9%-11% oxigen for 1.5 minutes interspersed with 1.5 minutes of 21% oxigen (normoxia), 15 times for a total of 45 minutes.
Placebo Comparator: Single session of Sham Acute Intermittent Hypoxia (Sham AIH)
Patients will breath 21% oxigen for 1.5 minutes interspersed with 1.5 minutes of room air, 15 times for a total of 45 minutes.
Experimental: Two successive sessions of AIH
Patients will breath 9%-11% oxigen for 1.5 minutes interspersed with 1.5 minutes of 21% oxigen (normoxia), 15 times for a total of 45 minutes.
Placebo Comparator: Two successive sessions of Sham AIH
Patients will breath 21% oxigen for 1.5 minutes interspersed with 1.5 minutes of room air, 15 times for a total of 45 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in grip strength
Time Frame: Baseline, immediately following intervention, and every 30 minutes for 5 hours
A dynamometer measures maximum gross grasp (kglb) averaged over three attempts with each hand. The minimum possible value of zero kg lb will be assigned when the participant cannot actively flex the fingers or grasp the dynamometer. Standard position includes the participant in a supported sitting position, with shoulder in adducted and in neutral rotation and the elbow flexed at 90 degrees. The forearm should be in neutral rotation. The arm should not be supported by an arm rest or research personnel.
Baseline, immediately following intervention, and every 30 minutes for 5 hours
Pinch Strength
Time Frame: Baseline, immediately following intervention, and every 30 minutes for 5 hours
A pinch gauge measures maximum pinch force (kglb) averaged over three attempts with each hand. The minimum possible value of zero kg will be assigned when the participant cannot actively squeeze the pinch meter between the thumb and index finger. Standard position includes the participant in a supported sitting position, with shoulder in adducted and in neutral rotation and the elbow flexed at 90 degrees. The gauge will be placed between the thumb and lateral surface of the index finger (lateral pinch).
Baseline, immediately following intervention, and every 30 minutes for 5 hours
9 Hole Peg Test
Time Frame: Baseline, immediately following intervention, and every 30 minutes for 5 hours
A measure of finger dexterity involving the placement of pegs from a container to holes on a board, and subsequent removal, as quickly as possible. The total number of seconds until task completion is recorded, as measured by when the participant touches the first peg to when the last peg is placed back into the container.
Baseline, immediately following intervention, and every 30 minutes for 5 hours
Box and Blocks test
Time Frame: Baseline, immediately following intervention, and every 30 minutes for 5 hours
A measure of manual dexterity that requires repeatedly moving 1-inch blocks from one side of a box to another in 60 seconds
Baseline, immediately following intervention, and every 30 minutes for 5 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

March 1, 2020

Study Completion (Anticipated)

July 1, 2020

Study Registration Dates

First Submitted

December 11, 2018

First Submitted That Met QC Criteria

December 11, 2018

First Posted (Actual)

December 12, 2018

Study Record Updates

Last Update Posted (Actual)

February 19, 2020

Last Update Submitted That Met QC Criteria

February 17, 2020

Last Verified

February 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Acute Intermittent Hypoxia

3
Subscribe